Regulation of autophagy and the ubiquitin-proteasome system by the FoxO transcriptional network during muscle atrophy

Nature Communications

Volumn 6, Issue , 2015, Pages

  Milan, Giulia ^a   Romanello, Vanina ^a   Pescatore, Francesca ^a,b   Armani, Andrea ^a   Paik, Ji Hye ^c   Frasson, Laura ^a   Seydel, Anke ^a   Zhao, Jinghui ^d   Abraham, Reimar ^e   Goldberg, Alfred L ^d   Blaauw, Bert ^b   DePinho, Ronald A ^f   Sandri, Marco ^a,b,g,h,i  

^a VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e U3 Pharma GmbH   (Germany)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g CNR   (Italy)

^h MCGILL UNIVERSITY   (Canada)

ⁱ TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SPECIFIC OF MUSCLE ATROPHY AND REGULATED BY TRANSCRIPTION; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR FOXO4; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, MOUSE; FOXO3 PROTEIN, MOUSE; FOXO4 PROTEIN, MOUSE; MTOR PROTEIN, MOUSE; PROTEASOME; PROTEIN KINASE B; TARGET OF RAPAMYCIN KINASE; UBIQUITIN;

AMINO ACID; CANCER; CATABOLISM; GENE EXPRESSION; MUSCLE; PROTEOMICS;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DETOXIFICATION; DNA REPAIR; FEMALE; GENE CONTROL; GENE DELETION; GENE EXPRESSION; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE DENERVATION; MUSCLE WEAKNESS; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE; STRESS; UBIQUITINATION; UNFOLDED PROTEIN RESPONSE; ANIMAL; DEFICIENCY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; GENETICS; GLUCONEOGENESIS; KNOCKOUT MOUSE; LYSOSOME; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; AUTOPHAGY; DNA REPAIR; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GLUCONEOGENESIS; LYSOSOMES; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; MUSCULAR ATROPHY; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TRANSCRIPTION, GENETIC; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; UNFOLDED PROTEIN RESPONSE;

EID: 84927636147     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7670     Document Type: Article

References (30)

1. Sandri, M. Signalling in muscle atrophy and hypertrophy. Physiology (Bethesda) 23, 160-170 (2008).
2. Mammucari, C. et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 6, 458-471 (2007).
3. Sandri, M. Autophagy in skeletal muscle. FEBS Lett. 584, 1411-1416 (2010).
4. Bodine, S. C. et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704-1708 (2001).
5. Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A. & Goldberg, A. L. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc. Natl Acad. Sci. USA 98, 14440-14445 (2001).
6. Lecker, S. H. et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 18, 39-51 (2004).
7. Sacheck, J. M. et al. Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J. 21, 140-155 (2007).
8. Sandri, M. et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117, 399-412 (2004).
9. Stitt, T. N. et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell 14, 395-403 (2004).
10. Zhao, J. et al. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab. 6, 472-483 (2007).
11. Xu, J. et al. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486. Kidney Int. 82, 401-411 (2012).
12. Yamazaki, Y. et al. The cathepsin L gene is a direct target of FOXO1 in skeletal muscle. Biochem. J. 427, 171-178 (2010).
13. Furuyama, T., Nakazawa, T., Nakano, I. & Mori, N. Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem. J. 349, 629-634 (2000).
14. Sandri, M. et al. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc. Natl Acad. Sci. USA 103, 16260-16265 (2006).
15. Ju, J. S., Varadhachary, A. S., Miller, S. E. & Weihl, C. C. Quantitation of 'autophagic flux' in mature skeletal muscle. Autophagy 6, 929-935 (2010).
16. Sartori, R. et al. BMP signalling controls muscle mass. Nat. Genet. 45, 1309-1318 (2013).
17. Santra, M. K., Wajapeyee, N. & Green, M. R. F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage. Nature 459, 722-725 (2009).
18. Melino, G. et al. Itch: a HECT-type E3 ligase regulating immunity, skin and cancer. Cell Death Differ. 15, 1103-1112 (2008).
19. Eijkelenboom, A. & Burgering, B. M. FOXOs: signalling integrators for homeostasis maintenance. Nat. Rev. Mol. Cell Biol. 14, 83-97 (2013).
20. Sandri, M. FOXOphagy path to inducing stress resistance and cell survival. Nat. Cell Biol. 14, 786-788 (2012).
21. Mizushima, N. & Komatsu, M. Autophagy: renovation of cells and tissues. Cell 147, 728-741 (2011).
22. Masiero, E. et al. Autophagy is required to maintain muscle mass. Cell Metab. 10, 507-515 (2009).
23. Castets, P. et al. Sustained activation of mTORC1 in skeletal muscle inhibits constitutive and starvation-induced autophagy and causes a severe, late-onset myopathy. Cell Metab. 17, 731-744 (2013).
24. Vilchez, D. et al. RPN-6 determines C. elegans longevity under proteotoxic stress conditions. Nature 489, 263-268 (2012).
25. Paik, J. H. et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128, 309-323 (2007).
26. Bothe, G. W., Haspel, J. A., Smith, C. L., Wiener, H. H. & Burden, S. J. Selective expression of Cre recombinase in skeletal muscle fibres. Genesis 26, 165-166 (2000).
27. Schuler, M., Ali, F., Metzger, E., Chambon, P. & Metzger, D. Temporally controlled targeted somatic mutagenesis in skeletal muscles of the mouse. Genesis 41, 165-170 (2005).
28. Raffaello, A. et al. JunB transcription factor maintains skeletal muscle mass and promotes hypertrophy. J. Cell Biol. 191, 101-113 (2010).
29. Schmidt, E. K., Clavarino, G., Ceppi, M. & Pierre, P. SUnSET, a nonradioactive method to monitor protein synthesis. Nat. Methods 6, 275-277 (2009).
30. Goodman, C. A. et al. Novel insights into the regulation of skeletal muscle protein synthesis as revealed by a new nonradioactive in vivo technique. FASEB J. 25, 1028-1039 (2011).